Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | S100A4 | P26447 | 1/20 | 0.51 |
| ▸ | SYK | P43405 | 1/20 | 0.49 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.49 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.45 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901046 | 0.85 | BACE1 (0.58) | MAPTSMN1; SMN2BACE1EGFRALDH1A1 | |
| SCHEMBL29772126 | 0.85 | BACE1 (0.58) | MAPTSMN1; SMN2BACE1EGFRALDH1A1 | |
| SCHEMBL8658097 | 0.85 | BACE1 (0.58) | MAPTSMN1; SMN2BACE1EGFRALDH1A1 | |
| SCHEMBL14176467 | 0.85 | MAPT (0.61) | MAPTSMN1; SMN2S100A4SYKAURKB | |
| SCHEMBL10479736 | 0.83 | BACE1 (0.56) | MAPTSMN1; SMN2BACE1EGFRALDH1A1 | |
| SCHEMBL3221434 | 0.81 | EGFR (0.58) | MAPTBACE1EGFRALDH1A1HSD17B10 | |
| SCHEMBL11486731 | 0.81 | BACE1 (0.54) | MAPTSMN1; SMN2BACE1EGFRALDH1A1 | |
| SCHEMBL16428951 | 0.81 | BACE1 (0.54) | MAPTBACE1EGFRALDH1A1HPGD | |
| Acetophenone SCHEMBL27691627 | 0.81 | MAPT (0.57) | MAPTSMN1; SMN2BACE1ALDH1A1HPGD | |
| SCHEMBL18585396 | 0.81 | MAPT (0.57) | MAPTSMN1; SMN2BACE1S100A4SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | claimed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | claimed |
| WO-2023136620-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | 건국대학교 산학협력단 | 2023-07-20 | — | — | WO | claimed |
| EP-0337434-B1 | Process for preparing diphenol monoesters substituted with aryl groups | HIMONT ITALIA (IT) | 1993-10-20 | — | — | EP | claimed |
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | disclosed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | disclosed |
| WO-2023136620-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | 건국대학교 산학협력단 | 2023-07-20 | — | — | WO | disclosed |
| EP-1656345-B1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2013-10-16 | — | — | EP | disclosed |
| US-7829571-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-11-09 | — | — | US | disclosed |
| US-7829571-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-11-09 | — | — | US | disclosed |
| US-20090124668-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2009-05-14 | — | — | US | disclosed |
| US-20090124668-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2009-05-14 | — | — | US | disclosed |
| US-7163937-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-16 | — | — | US | disclosed |
| US-7163937-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-16 | — | — | US | disclosed |
| EP-0337434-B1 | Process for preparing diphenol monoesters substituted with aryl groups | HIMONT ITALIA (IT) | 1993-10-20 | — | — | EP | disclosed |
| EP-0190815-B1 | PROCESS FOR PRODUCING AROMATIC DIOLS | CELANESE CORPORATION (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0337434-A2 | Process for preparing diphenol monoesters substituted with aryl groups | HIMONT ITALIA S.r.l. (IT) | 1989-10-18 | — | — | EP | disclosed |
| EP-0178929-B1 | PROCESS FOR PRODUCING AROMATIC DIOLS AND THEIR ESTER AND ETHER DERIVATIVES | CELANESE CORPORATION (US) | 1989-03-22 | — | — | EP | disclosed |
| EP-0190815-A2 | Process for producing aromatic diols | CELANESE CORPORATION (US) | 1986-08-13 | — | — | EP | disclosed |
| EP-0178929-A1 | Process for producing aromatic diols and their ester and ether derivatives | CELANESE CORPORATION (US) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124668-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCL11, CCL2, CCR1 | MAPT 4523/4885SMN1; SMN2 3850/4885BACE1 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.